China grants country’s first COVID-19 vaccine patent to CanSino: Report


Source: channelnewsasia.com channelnewsasia.com

Key Topics in this News Article:

News Snapshot:

BEIJING: China's vaccine specialist CanSino Biologics has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the country's intellectual property regulator. It is the first COVID-19 vaccine patent granted by China, state-owned newspaper People's Daily reported on Sunday (Aug 16). The paper cited documents published by China's National Intellectual Property Administration saying that the patent was issued on Aug 11. READ: China Sinopharm's potential COVID-19 vaccine triggers antibodies in clinical trials Saudi Arabia said this month it plans to begin phase 3 clinical trials for the CanSino vaccine. CanSino has said...